Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells.

Halder J, Landen CN Jr, Lutgendorf SK, Li Y, Jennings NB, Fan D, Nelkin GM, Schmandt R, Schaller MD, Sood AK.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8829-36.

2.

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

Bonome T, Lee JY, Park DC, Radonovich M, Pise-Masison C, Brady J, Gardner GJ, Hao K, Wong WH, Barrett JC, Lu KH, Sood AK, Gershenson DM, Mok SC, Birrer MJ.

Cancer Res. 2005 Nov 15;65(22):10602-12.

3.

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.

Landen CN Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G, Sood AK.

Cancer Res. 2005 Aug 1;65(15):6910-8.

4.

Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.

Thaker PH, Yazici S, Nilsson MB, Yokoi K, Tsan RZ, He J, Kim SJ, Fidler IJ, Sood AK.

Clin Cancer Res. 2005 Jul 1;11(13):4923-33.

5.

Focal adhesion kinase: in command and control of cell motility.

Mitra SK, Hanson DA, Schlaepfer DD.

Nat Rev Mol Cell Biol. 2005 Jan;6(1):56-68. Review.

PMID:
15688067
6.

Cancer statistics, 2005.

Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ.

CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30. Erratum in: CA Cancer J Clin. 2005 Jul-Aug;55(4):259.

7.

Focal adhesion kinase overexpression induces enhanced pathological retinal angiogenesis.

Kornberg LJ, Shaw LC, Spoerri PE, Caballero S, Grant MB.

Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4463-9.

PMID:
15557455
8.

Liposomes modified with cyclic RGD peptide for tumor targeting.

Dubey PK, Mishra V, Jain S, Mahor S, Vyas SP.

J Drug Target. 2004 Jun;12(5):257-64.

PMID:
15512776
9.

Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.

Sood AK, Coffin JE, Schneider GB, Fletcher MS, DeYoung BR, Gruman LM, Gershenson DM, Schaller MD, Hendrix MJ.

Am J Pathol. 2004 Oct;165(4):1087-95.

10.

Binding and interstitial penetration of liposomes within avascular tumor spheroids.

Kostarelos K, Emfietzoglou D, Papakostas A, Yang WH, Ballangrud A, Sgouros G.

Int J Cancer. 2004 Nov 20;112(4):713-21.

11.

Unlocking the potential of the human genome with RNA interference.

Hannon GJ, Rossi JJ.

Nature. 2004 Sep 16;431(7006):371-8. Review.

PMID:
15372045
12.

Therapeutic potential of retroviral RNAi vectors.

Devroe E, Silver PA.

Expert Opin Biol Ther. 2004 Mar;4(3):319-27. Review.

PMID:
15006726
13.

Focal adhesion kinase: an integrin-linked protein tyrosine kinase.

Schaller MD, Parsons JT.

Trends Cell Biol. 1993 Aug;3(8):258-62.

PMID:
14731743
14.

CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.

Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE.

Oncogene. 2004 Jan 15;23(2):465-73.

PMID:
14724575
15.

RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity.

Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE.

Biochem Biophys Res Commun. 2003 Nov 21;311(3):786-92.

PMID:
14623342
16.

Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis.

Langley RR, Ramirez KM, Tsan RZ, Van Arsdall M, Nilsson MB, Fidler IJ.

Cancer Res. 2003 Jun 1;63(11):2971-6.

17.

Role of docetaxel in the treatment of newly diagnosed advanced ovarian cancer.

Vasey PA.

J Clin Oncol. 2003 May 15;21(10 Suppl):136s-144s.

PMID:
12743129
18.

Gene silencing by systemic delivery of synthetic siRNAs in adult mice.

Sørensen DR, Leirdal M, Sioud M.

J Mol Biol. 2003 Apr 4;327(4):761-6.

PMID:
12654261
19.

Differential regulation of cell motility and invasion by FAK.

Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, Huang S, Li E, Nemerow GR, Leng J, Spencer KS, Cheresh DA, Schlaepfer DD.

J Cell Biol. 2003 Mar 3;160(5):753-67.

20.

Focal adhesion kinase as a potential target in oncology.

McLean GW, Avizienyte E, Frame MC.

Expert Opin Pharmacother. 2003 Feb;4(2):227-34. Review.

PMID:
12562313

Supplemental Content

Support Center